Weight, measurements, appetite levels, side effects, energy, sleep quality, and food intake should all be tracked from day one
Semaglutide (Wegovy) a licensed GLP-1 receptor agonist approved by the MHRA for weight management in eligible adults, as assessed in NICE technology appraisal TA875
Dont Rush Your Dose Increases Many patients feel the urge to increase their dose quickly, but sticking at a lower dose for longer (especially if its working) can meaningfully reduce your monthly spend without affecting your results
Compounded peptide alternatives The compounded peptide market has become one of the most significant alternative pathways for people who cannot access or afford brand-name tirzepatide
Who Is a Good Candidate for Retatrutide
The connection between weight loss methods and hair outcomes GLP-1 medications are not the only weight loss approach that can trigger hair shedding